Cusat Gets Patent for Digital Evidence Fingerprint Tech
Cochin University researchers patent a system to create tamper-proof digital fingerprints for evidence, boosting forensic reliability for law enforcement. Read more about this innovation.
Category : Search result: semaglutide patent expiry
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Bitcoin Braces for $23B Options Expiry, High Volatility
Bitcoin's price faces intense pressure as $23 billion in options contracts expire next Friday, threatening to spike volatility. Traders brace for downside risk amid a fragile market. Read the full analysis.
Court sets interim royalty rate at $0.365 per device
London High Court grants Acer, Asus, and Hisense an interim license to use Nokia's video patents. Judge sets royalty at $0.365 per device, a middle ground in the FRAND dispute. Nokia plans to appeal. Read the full details.
India's Patent Filings Cross 1 Lakh, Domestic Share at 62%
India's patent applications crossed 1.1 lakh in FY25, a 20% jump, with domestic innovators driving 62% of filings. IPR growth signals a robust R&D surge. Read more.
National Patent for Ladakh's Wastewater Hydroponic Farming
Govind Ballabh Pant Institute's Ladakh centre patents a hydroponic system using treated wastewater, boosting food security in fragile Himalayan ecosystems. Read about this climate-smart breakthrough.
Pilibhit Fuel Pump's Licence Suspended Over Lease Dispute
Pilibhit district administration suspends diesel licence & cancels NOC of Tiwari Filling Station after land lease expired. Action follows complaint by HC lawyer. Details inside.
India & European Patent Office Deepen Collaboration on Patents
India and the European Patent Office strengthen ties, emphasizing the crucial role of patents in the deep tech era for innovation and economic growth. Discover the key insights from EPO's Roberta Romano-Götsch.
Court Rejects Ozempic Patent Extension, Boosts Generic Drug Access
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Lock-in period ends for Groww, Lenskart, Pine Labs shares
Lock-in periods for shares of Groww, Lenskart, and Pine Labs expire this week, freeing shares worth over ₹6,500 crore for potential trading. Understand the market implications.
Karnataka HC: Lapsed DL Not Proof of Negligence
Karnataka High Court clarifies that not holding a valid driving licence does not automatically mean a rider was negligent in an accident. Read the full legal analysis.
India-Russia Summit: Key Outcomes & UPSC Insights
India & Russia sign 16 pacts, chart roadmap till 2030. Key takeaways on labour mobility, trade, defence & nuclear energy. Essential analysis for UPSC aspirants on bilateral ties, repo rate, labour codes & more.
Delhi HC sides with Dr Reddy's in semaglutide patent case
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
India's Drug Patent Wars: Need for Special Courts?
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
Hidden Stroke Risks in Young, Healthy Adults
Dr Sudhir Kumar reveals 5 hidden stroke causes affecting young, healthy individuals. Learn the signs, risks, and prevention tips beyond blood pressure and exercise.
India's Startup Patent Crisis: Filings Up, Grants Down
Indian startups filed 13,089 patents since 2021, but only 2,174 were granted. Experts reveal a focus on optics over innovation. Discover the four forces driving this trend and what India must change.
Fitterfly Wins Patent for Diabetes Management Technology
Fitterfly, a division of PB Health, has secured a patent for its PGR technology, aiming to revolutionize personalized diabetes care and improve patient outcomes in India.
Trump: USMCA Trade Deal Faces Expiry or New Agreement
Former President Donald Trump states the USMCA trade pact will either expire or be renegotiated in its upcoming 2025 review. Get the latest on this critical trade development.
WHO issues first global guidelines for GLP-1 obesity drugs
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
Dr Reddy's Wins Delhi HC Nod to Export Semaglutide
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Rajasthan Panchayat Pradhans Seek Admin Role as Terms End
With terms of 325 Panchayat Samitis ending on Dec 10, Rajasthan's Pradhans urge the state to appoint interim administrators to prevent a rural development halt. Read their demands.
HC: Driving Licence Valid 30 Days After Expiry, Covers Accidents
Punjab & Haryana High Court rules driving licences remain valid for 30 days after expiry. Accident on grace period's final day is covered by insurance. Read key details.
Oral Ozempic 2.0: Game-Changer Weight Loss Pills
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
Himachal Dental Professor Wins UK Design Patent
Dr. Rajeev Sharma from Himachal Dental College receives UK design patent for innovative medical utility tray. Breakthrough in medical device innovation from Indian professor.
Kajol, Twinkle's 'Two Much' Talk Show Wraps With Controversy
Kajol and Twinkle Khanna's talk show 'Two Much' concluded after 8 candid episodes, sparking debates on infidelity and marriage. A special bonus with cricketers released post-season.
Indian Companies Set for Semaglutide Device Windfall
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Renewable Energy Firm Gets EV Charging Patent
Indian renewable energy company secures patent for EV charging technology, boosting stock by 5%. Details on innovation and market impact revealed.
Michelle Obama's Weight Loss Sparks Ozempic Speculation
Michelle Obama faces Ozempic rumors after revealing slimmer frame in Annie Leibovitz photoshoot. Social media erupts with speculation despite no evidence. Read the full story.
TCS, Wipro sued for patent infringement in US courts
Indian IT giants TCS and Wipro face fresh patent lawsuits in Texas courts over cloud and telecom technologies. Legal challenges mount as firms expand into software products. Read analysis.
India's Own Gene Editing Tech Aids Cheaper Crop Breeding
ICAR patents indigenous TnpB gene editing technology, offering a miniature alternative to CRISPR. This breakthrough promises cheaper, IP-free GE crop development for Indian farmers.
Page 3 of 4